Medi-Tech Insights Get in touch

Global Benign Prostatic Hyperplasia (BPH) Surgical Treatment Market Size & Trends Report Segmented by Drug Type (Alpha-Blockers, 5-Alpha Reductase Inhibitors), Procedure Type (TURP, Laser), Therapy (Mono, Combination), End-user (Hospitals, ASCs) & Regional Forecast to 2031

Request Quote Download FREE Sample
Single User

Table of Contents

  1. Introduction
    • Introduction
    • Market Scope
      • Market Definition
      • Segments Covered
      • Regional Segmentation
    • Research Timeframe
    • Currency Considered
    • Study Limitations
    • Stakeholders
    • List of Abbreviations
    • Key Conferences and Events (2026-2027)
  2. Research Methodology
    • Secondary Research
    • Primary Research
    • Market Estimation
      • Bottom-Up Approach
      • Top-Down Approach
    • Market Forecasting
  3. Executive Summary
    • Benign Prostatic Hyperplasia (BPH) Surgical Treatment Marke"4">
    • Market Overview
      • Market Dynamics
        • Drivers
          • Increasing ageing male population & growing BPH prevalence
          • Shift toward minimally invasive surgical therapies (MISTs)
          • Technological innovation and clinical evidence growth
          • Outpatient surgery & ASC expansion
          • Increased awareness & diagnostic access
        • Restraints
          • Cost and reimbursement limitations
          • Surgeon learning curve and training demands
          • Regulatory challenges
        • Opportunities
          • Product differentiation around sexual-function preservation & QoL
          • Health economic evidence & bundled-payment models
          • Adjunct diagnostics & personalized therapy matching
        • Key Market Trends
          • Rising adoption of enucleation/laser procedures
          • Growing demand in emerging markets
        • Unmet Market Needs
        • Industry Speaks
  1. Global Benign Prostatic Hyperplasia (BPH) Surgical Treatment Market Size & Forecast (2024-2031), By Drug Type USD Billion
    • Introduction
    • Alpha-Blockers
    • 5-Alpha Reductase Inhibitors
    • Other Drug Types
  2. Global Benign Prostatic Hyperplasia (BPH) Surgical Treatment Market Size & Forecast (2024-2031), By Procedure Type, USD Billion
    • Introduction
    • Transurethral Resection of the Prostate (TURP)
    • Laser Surgeries
    • UroLift Procedures
    • Rezum Procedures
    • Robot-Assisted Waterjet Ablation
    • Prostatic Stents
    • Transurethral Microwave Thermotherapy (TUMT)
    • Transurethral Needle Ablation of the Prostate (TUNA)
    • Prostatic Arterial Embolization (PAE)
    • Other Procedure Types
  3. Global Benign Prostatic Hyperplasia (BPH) Su Market Size & Forecast (2024-2031), By Therapy, USD Billion
    • Introduction
    • Mono Therapy
    • Combination Therapy
  4. Global Benign Prostatic Hyperplasia (BPH) Surgical Treatment Market Size & Forecast (2024-2031), By End User, USD Billion
    • Introduction
    • Hospitals
    • Ambulatory Surgical Centers (ASCs)
    • Other End Users
  5. Global Benign Prostatic Hyperplasia (BPH) Surgical Treatment Market Size & Forecast (2024-2031), By Region, USD Billion
    • Introduction
    • North America Benign Prostatic Hyperplasia (BPH) Surgical Treatment Market Size & Forecast (2024-2031), By Country, USD Billion
      • US
        • Market Size & Forecast, By Drug Type (USD Billion)
        • Market Size & Famp; Forecast, By Therapy (USD Billion)
        • Market Size & Forecast, By End User (USD Billion)
      • Canada
        • Market Size & Forecast, By Drug Type (USD Billion)
        • Market Size & Forecast, By Procedure Type (USD Billion)
        • Market Size & Forecast, By Therapy (USD Billion)
        • Market Size & Forecast, By End User (USD Billion)
    • Europe Benign Prostatic Hyperplasia (BPH) Surgical Treatment Market Size & Forecast (2024-2031), By Country, USD Billion
      • UK
        • Market Size & Forecast, By Drug Type (USD Billion)
        • Market Size & Forecast, By Procedure Type (USD Billion)
        • Market Size & Forecast, By Therapy (USD Billion)
        • Market Size & Forecast, By End User (USD Billion)
      • Germany
        • Market Size & Forecast, By Drug Type Forecast, By Therapy (USD Billion)
        • Market Size & Forecast, By End User (USD Billion)
      • France
        • Market Size & Forecast, By Drug Type (USD Billion)
        • Market Size & Forecast, By Procedure Type (USD Billion)
        • Market Size & Forecast, By Therapy (USD Billion)
        • Market Size & Forecast, By End User (USD Billion)
      • Italy
        • Market Size & Forecast, By Drug Type (USD Billion)
        • Market Size & Forecast, By Procedure Type (USD Billion)
        • Market Size & Forecast, By Therapy (USD Billion)
        • Market Size & Forecast, By End User (USD Billion)
      • Spain
        • Market Size & Forecast, By Drug Type (USD Billion)
        • Market Size & Forecast, By Procedure Type (USD Billion)
        • Market Size & Forecast, By Therapy (USD Billket Size & Forecast, By Drug Type (USD Billion)
        • Market Size & Forecast, By Procedure Type (USD Billion)
        • Market Size & Forecast, By Therapy (USD Billion)
        • Market Size & Forecast, By End User (USD Billion)
    • Asia Pacific (APAC) Benign Prostatic Hyperplasia (BPH) Surgical Treatment Market Size & Forecast (2024-2031), By Country, USD Billion
      • China
        • Market Size & Forecast, By Drug Type (USD Billion)
        • Market Size & Forecast, By Procedure Type (USD Billion)
        • Market Size & Forecast, By Therapy (USD Billion)
        • Market Size & Forecast, By End User (USD Billion)
      • Japan
        • Market Size & Forecast, By Drug Type (USD Billion)
        • Market Size & Forecast, By Procedure Type (USD Billion)
        • Market Size & Forecast, By Therapy (USD Bi>
        • Market Size & Forecast, By Drug Type (USD Billion)
        • Market Size & Forecast, By Procedure Type (USD Billion)
        • Market Size & Forecast, By Therapy (USD Billion)
        • Market Size & Forecast, By End User (USD Billion)
      • Rest of Asia Pacific
        • Market Size & Forecast, By Drug Type (USD Billion)
        • Market Size & Forecast, By Procedure Type (USD Billion)
        • Market Size & Forecast, By Therapy (USD Billion)
        • Market Size & Forecast, By End User (USD Billion)
    • Latin America (LATAM) Benign Prostatic Hyperplasia (BPH) Surgical Treatment Market Size & Forecast (2024-2031), USD Billion
      • Market Size & Forecast, By Drug Type (USD Billion)
      • Market Size & Forecast, By Procedure Type (USD Billion)
      • Market Size & Forecast, By Therapy (USD Billion)
      • Market Size &Africa (MEA) Benign Prostatic Hyperplasia (BPH) Surgical Treatment Market Size & Forecast (2024-2031), USD Billion
        • Market Size & Forecast, By Drug Type (USD Billion)
        • Market Size & Forecast, By Procedure Type (USD Billion)
        • Market Size & Forecast, By Therapy (USD Billion)
        • Market Size & Forecast, By End User (USD Billion)
  • Competitive Landscape
    • Key Players and their Competitive Positioning
      • Key Player Comparison
      • Segment-wise Player Mapping
      • Market Share Analysis (2025)
      • Company Categorization Matrix
        • Dominants/Leaders
        • New Entrants
        • Emerging Players
        • Innovative Players
      • Key Strategies Assessment, By Player (2023-2025)
        • New Product Launches
        • Partnerships, Agreements, & Collaborations
        • Mergers & Acquisitions
        • Geographic Expansion
    1. Company Profiles*

    (Business Overview, Financial Performance**, Products Offered, Recent Developments)

    • GSK plc.
    • Eli Lilly and Company
    • Boston Scientific Corporation
    • Teleflex Incorporated
    • PROCEPT BioRobotics Corporation
    • Olympus Corporation
    • Astellas Pharma Inc.
    • Asahi Kasei Corporation
    • Coloplast Group
    • AbbVie Inc.
    • Other Prominent Players

    Note: *Indicative list

    **For listed companies

    Related Reports

    View All Research Reports